Authors
Latest:
Adalimumab Biosimilar Now Available at Significant Discount to HumiraBoehringer Ingelheim’s unbranded adalimumab-adbm biosimilar will be available at an 81% discount to adalimumab (Humira).
Latest:
Why M&A is back; AI regulations lacking; quantum sensing investment, and more: Pharma Pulse for February 23, 2024The latest news for pharma industry insiders.
Latest:
Challenges and Benefits of Implementing IDMP in the Pharmaceutical IndustryThe Identification of Medicinal Product framework seeks to establish a common language for identifying, documenting, and exchanging information about medicinal products.
Latest:
Reimagining Closed-Loop Marketing Strategies for Pharma CompaniesThe pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Latest:
Closing a Key Gap in DSCSA ComplianceOutlining the work of the Open Credentialing Initiative in establishing digital proof of identity, licensure status, and authorship using digital wallets and verifiable credentials
Latest:
What the Pharma Industry Can Learn from the Food Sector about Digital Quality ManagementPharma compliance requires stringent quality assurance in order to ensure patient safety, but the default for many pharma companies is still to use manual processes for supplier vetting and reporting. Gaëlle Jaron looks at how the food industry might inspire pharma to transform its processes
Latest:
Environmental Sustainability: An Imperative for the Life Sciences SectorGiven the biopharma sector‘s complex set of networks and supply chains, so it is not straightforward to shift towards net zero across all operations.
Latest:
Why AI Advances in CGT Require Getting Data RightAddressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.
Latest:
Traceability's Latest CurveOur December analysis of the twists and turns in the Drug Supply Chain Security Act is a timely one, as the FDA recently again pushed back the deadline for complying with new mandates on tracking and tracing drugs at the package level.
Latest:
Assessing Adoption of Hybrid DtP ModelsThe benefits of hybrid direct-to-patient studies and supply chain structures in boosting drug access, influencing clinical trial design
Latest:
Exploring Uses of RFID TechnologyOffer potential to improve patient care, including in medication adherence.
Latest:
DSCSA Beyond the November Deadline: Operationalize Compliance in the WarehouseCompliance with the Drug Supply Chain Security Act (DSCSA) is crucial to ensure a secure and efficient pharmaceutical supply chain. Industry experts share strategies for implementing serialized data tracking, overcoming compliance challenges, and fostering collaboration across the supply chain to maintain operational efficiency and patient safety.
Latest:
Rethinking Pharma Commercialization Models as Healthcare EvolvesHow cross-functional commercialization teams can hone their role within clinical management pathways, communicate value to all stakeholders, achieve excellence in evidence generation, and maximize the opportunities of digital technologies
Latest:
Precision-based DiagnosticsPrecision-based diagnostic approaches can help us improve patient outcomes and reach patient success sooner
Latest:
A First-Class Patient Engagement Service: Do Strategic Partnerships Hold the Key?Delivering a first-class patient engagement approach is complex enough in a large pharma market. For smaller European markets, it can be even more challenging. Ian Riches looks at how pharma companies can put all patients at the center of their engagement plans, no matter which country they live in.
Latest:
CO2 Shortages and the Case for Permanent ULT InfrastructureThe UK‘s imminent CO2 shortage crisis is second time in less than a year that CO2 shortages have threatened critical cold chains. As the demand for COVID-19 vaccines, mRNA-based therapies and precision medicine treatments grows, organizations will have to rethink their ultra-low temperature (ULT) strategies to prevent these shortages from impacting the pharma cold chain, writes Shea Vincent.
Latest:
Future of Personalized Medicine Hinges on Pharma Executives Revolutionizing Business ModelsThe era of big pharma as product-first companies must end, as services become the larger priority.
Latest:
How pharmacies can safeguard Covid-19 vaccine dosesBest practices for pharmacies in storage, monitoring and maintenance of their Covid vaccine shipments
Latest:
Rising sea level: The transportation of pharmaceuticals by sea continues to gain momentum in the quest for greater supply chain resilienceWhen shipping pharmaceuticals internationally, the decision of ocean shipping versus air shipping might seem obvious if the speed of air shipping is the only factor at play when sending sensitive medical supplies and drugs. For the last several years, however, more companies have decided to embrace ocean shipping as a means of delivering their medicines. Industry experts Alan Kennedy and Allan Klinge discuss how, with more cold chain control, a lower carbon footprint and lower costs, ocean-going vessels often have clear advantages over air freight.
Latest:
Improving Cross-Industry Collaboration on Drug Discount ProgramsHow teamwork among safety-net healthcare providers and pharma can make the difference.
Latest:
Advent International, Warburg Pincus Complete $4.25 Billion Acquisition of Baxter’s BioPharma Solutions BusinessThe newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.
Latest:
Study Highlights PBMs’ Role in Drug PricesAn analysis by 3 Axis Advisors has found that there is a large variability in pharmacy reimbursement of prescription drugs depending on PBM contracts with insurers. This creates a system with huge inconsistencies on the prices of both generics and branded products.
Latest:
Pharma Pulse 12/18/24: The Art of Cross-Cultural Communication in Pharma, The Role of a Digital Navigator in Mental Health & moreThe latest news for pharma industry insiders.
Latest:
Mark Cuban’s Cost Plus Drugs Partners with Price.comThe two company’s will provide consumers with a platform where they can compare drug prices.
Latest:
Continued Affordability Challenges in the OffingWill result from Medicare reforms, despite increased drug uptake.
Latest:
Why Pharmaceutical Products Need Sustainable PackagingOne packaging aspect—the tape—is often overlooked, but is a valuable component of the shipping process.
